Comparing Atogepant vs Emgality
| Atogepant | Emgality (galcanezumab) |
|
|---|
| Atogepant | Emgality (galcanezumab) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Chronic Migraine, Migraine Prevention, Headache, Migraine. Atogepant may also be used for purposes not listed in this medication guide. |
Prescription only
Emgality is an injectable medication that can be self-administered subcutaneously (under the skin) once monthly for the prevention of migraine in adults or during a cluster headache period when used... View more |
Related suggestions Migraine Prevention (Migraine Prophylaxis)
|
|||||||
| More about Atogepant | More about Emgality (galcanezumab) | ||||||||
| Ratings & Reviews | |||||||||
|
Atogepant has an average rating of 8.2 out of 10 from a total of 203 ratings on Drugs.com. 73% of reviewers reported a positive effect, while 6% reported a negative effect. |
Emgality has an average rating of 5.3 out of 10 from a total of 500 ratings on Drugs.com. 38% of reviewers reported a positive effect, while 44% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Atogepant side effects |
View all Emgality side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
N/A |
N/A |
||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Emgality prices |
||||||||
| Dosage Forms | |||||||||
|
N/A |
|
||||||||
| Brand Names | |||||||||
| Qulipta |
N/A |
||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
11 hours |
648 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 194 drugs are known to interact with Atogepant:
|
A total of 3 drugs are known to interact with Emgality:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | |||||||||
|
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|||||||||
| First Approval Date | |||||||||
|
September 28, 2021 |
September 27, 2018 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.